The genetic complexity, clinical variability, and inaccessibility of affected tissue in neurodegenerative and neuropsychiatric disorders have largely prevented the development of effective disease-modifying therapeutics. A precision medicine approach that integrates genomics, deep clinical phenotyping, and patient stem cell models may facilitate identification of underlying biological drivers and targeted drug development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.stem.2018.05.019 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!